Biomerica
BMRA

Biomerica (BMRA) earnings history

Most recent quarter

Period end
Feb 28, 2025
EPS actual
−$0.48
Revenue
$1.1M
Reported
Apr 14, 2025

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q3 2025Apr 14, 2025$0.00−$0.48+0.00%$1.1MSEC
Q2 2025Jan 14, 2025$0.00−$0.48+0.00%$1.6MSEC
Q3 2023Apr 14, 2023$0.16−$0.96−700.00%$1.1MSEC
Q2 2023Jan 13, 2023$0.00−$0.96+0.00%$1.5MSEC
Q1 2023Oct 13, 2022−$0.16−$1.28−700.00%$1.6M
Q3 2022Apr 14, 2022−$0.80−$0.08+90.00%$7.6M
Q2 2022Jan 12, 2022−$0.64−$0.72−12.50%$4.6M
Q1 2022Oct 14, 2021−$0.96−$0.96+0.00%$1.3M
Q4 2021Aug 27, 2021−$0.88−$0.96−9.09%$1.1M
Q3 2021Apr 14, 2021−$1.20−$1.20+0.00%$3.6M
Q2 2021Jan 14, 2021−$0.91−$1.04−14.70%$1.4M
Q1 2021Oct 15, 2020−$0.64−$1.12−75.00%$1.1M
Q3 2020Apr 14, 2020−$0.52−$0.72−38.46%$1.2M

Quarterly revenue

Q3 2020
$1.2M
Q1 2021
$1.1M
Q2 2021
$1.4M
Q3 2021
$3.6M
Q4 2021
$1.1M
Q1 2022
$1.3M
Q2 2022
$4.6M
Q3 2022
$7.6M
Q1 2023
$1.6M
Q2 2023
$1.5M
Q3 2023
$1.1M
Q2 2025
$1.6M
Q3 2025
$1.1M

Frequently asked questions

  • When did Biomerica (BMRA) last report earnings?

    Biomerica last reported on Apr 14, 2025, covering fiscal Q3 2025.

  • Did BMRA beat earnings estimates?

    Biomerica reported EPS of −$0.48 for Q3 2025, in line with the $0.00 consensus estimate.

  • How much revenue did BMRA report last quarter?

    Biomerica reported $1.1M in revenue for Q3 2025.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.